Hisun Pharma Unit Receives Veterinary Drug Approval for Combination Spot-On
Hisun Pharmaceutical (600267) announced on September 14, 2026, that its controlling subsidiary Zhejiang Hisun Animal Health Products Co. , Ltd. has received the approval document for a veterinary drug product registration number issued by the Ministry of Agriculture and Rural Affairs for a compound fipronil, praziquantel and moxidectin spot-on solution.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmaceuticals, with intensity 20/100 and 70% confidence over a medium term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.